Robarts Scientist and Professor, Western University Full Biography Cancers of Interest Blood Prostate Projects at BioCanRx In vivo human therapeutic cell tracking using a [19F]-perfluorocarbon cellular MRI contrast agent: Phase I feasibility and preliminary safety trial
Tag: Immunotherapy
Marcus Butler
Clinician Investigator, Princess Margaret Cancer Centre Full Biography Cancers of Interest Bladder Cervical Esophageal Gastric Gynecologic Ovarian Pancreatic Skin Research Interests and Clinical Approach Clinical trials research focuses on adoptive immunotherapy for multiple different solid tumor types Projects at BioCanRx Phase Ib trial of pembrolizumab administered following adoptive cell therapy-… Read more »
Tania Bubela
Professor, Faculty of Health Sciences Dean, Health Sciences, Simon Fraser University Full Biography Research and clinical approaches My research program focuses on three main areas in health and biotechnology law and policy: Knowledge translation in health, biotechnology and new technologies in biomedicine. Impacts of innovation, commercialization/open science and intellectual property policies on… Read more »
Jonathan Bramson
Professor, McMaster University Department of Pathology and Molecular Medicine Vice-Dean, Research, Faculty of Health Sciences, McMaster University Director, Fraunhofer Project Centre for Biomedical Engineering and Advanced Manufacturing Canada Research Chair in Translational Cancer Immunology John Bienenstock Chair in Molecular Medicine Full Biography Cancers of Interest Bone Breast Lung Projects at BioCanRx Phase… Read more »
John Bell
Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute Professor, Depts. of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa Program Director, Ontario Regional Biotherapeutics Program(ORBiT), Ontario Institute for Cancer Research, OICR Director, Canadian Oncolytic Virus Consortium (COVCo), Terry Fox New Frontiers Program Project Grant Scientific Director, BioCanRx, Biotherapeutics for Cancer Treatment, Network of… Read more »
Harold Atkins
Scientist, Cancer Therapeutics Program Ottawa Hospital Research Institute Attending Physician, Blood and Marrow Transplant Program The Ottawa Hospital Associate Professor, Clinical Hematology University of Ottawa Full Biography Cancers of Interest Blood Cancer Recent Articles HQP Development Committee
Rebecca Auer
Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute Professor, Department of Surgery and Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa Surgical Oncologist, Faculty of Medicine, Department of Biochemistry, Immunology & Microbiology, The Ottawa Hospital Tier 2 Clinical Research Chair, Perioperative Cancer Therapeutics, University of Ottawa Scientific Director, Cancer Therapeutics… Read more »
Global News takes a look into the science of immunotherapy
Could immunotherapy – a novel method of treatment that harnesses your body’s own immune system to fight cancer – be the new front line for cancer treatment? Global News 16X9 is providing viewers with a look at immunotherapy – a concept that is being dubbed the fourth pillar for cancer treatment. This approach to… Read more »